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West Nile virus has been isolated for the first time in
Mexico, from a sick person and from mosquitoes (Culex
quinquefasciatus). Partial sequencing and analysis of the 2
isolates indicate that they are genetically similar to other
recent isolates from northern Mexico and the western
United States. 
S
everal recent reports (1–7) have documented the wide-
spread geographic distribution of West Nile virus
(WNV) in Mexico, but until now, no autochthonous human
cases of illness due to this virus have been reported from
the republic. Likewise, limited entomologic surveillance
has been conducted in Mexico, and no information is
available on the actual mosquito vectors of WNV in the
republic. All Mexican WNV isolates studied to date have
come from dead equines or birds (2,7,8). We report the
first isolations of WNV from a sick person and from a pool
of Culex quinquefasciatus mosquitoes and describe their
phylogenetic relationship to other representative WNV
strains from the United States and Mexico.
The Study
Mosquitoes were collected from June to September
2003 at the Ejido Francisco Villa, Municipality of
Pesqueria, State of Nuevo Leon (25°47′N, 100°03′W),
with CDC-type light traps baited with dry ice and mechan-
ical aspiration from resting sites on vegetation and in hous-
es. The area is located ≈40 km northeast of Monterrey and
consists of mixed suburban housing and agriculture.
Average annual rainfall in the region is 550 mm; the mean
annual temperature is 28°C. After collection, the mosqui-
toes were placed on dry ice for transport back to the
Medical Entomology Laboratory, Faculty of Biological
Sciences, Autonomous University of Nuevo Leon,
Monterrey, where they were separated into pools of ≈10
insects each, based on species, date, and method of collec-
tion (Table 1). The mosquitoes were stored in a mechani-
cal freezer at –70°C and later transported on dry ice to the
University of Texas Medical Branch (UTMB) to be
processed for virus isolation. A total of 2,297 mosquitoes,
representing 4 genera and 11 species, were tested in 238
pools (Table 1). Individual mosquito pools were titrated
manually in sterile, Ten Broeck tissue grinders containing
1.0 mL of phosphate-buffered saline, pH 7.4, containing
30% fetal bovine serum and antimicrobial agents (peni-
cillin, streptomycin, and amphotericin). The resultant sus-
pension was centrifuged at 12,000 rpm for 5 min; then 200
µL of the supernatant was injected into a flask culture of
Vero cells. After the solution was absorbed for 1 h at 37°C,
maintenance medium (9) was added; cultures were main-
tained in an incubator at 37°C and examined daily for evi-
dence of viral cytopathic effect (CPE) for 14 days. 
A single pool of Cx. quinquefasciatus yielded a virus
isolate, designated NL-54, which produced CPE on
approximately day 7. The isolate was identified as WNV
by immunofluorescence, hemagglutination-inhibition (HI)
test, complement-fixation test, VecTest WNV/SLE antigen
assay (Medical Analysis Systems, Camarillo, CA, USA),
and reverse transcription–polymerase chain reaction (RT-
PCR) (9,10). 
The WNV human isolate was from a 62-year-old
Mexican woman living in the municipality of Etchojoa
(near Ciudad Obregon) in Sonora State. The patient had no
history of travel during the preceding 2 months. She visit-
ed a local hospital in July 2004 with symptoms of fever,
headache, vomiting, arthralgias, and myalgia. Her temper-
ature was 38°C upon examination, and no neurologic
symptoms were noted. An acute-phase blood sample was
obtained, and a presumptive diagnosis of dengue fever was
made. The patient was sent home and subsequently com-
pletely recovered. When RT-PCR using dengue primers
was negative on the acute-phase serum, a culture was per-
formed. WNV was isolated from the sample at the State
Public Health Laboratory in Sonora and at UTMB, upon
culture in Vero cells. HI tests conducted on the acute-phase
serum at UTMB with West Nile, St. Louis encephalitis,
yellow fever, dengue 1, and dengue 2 viral antigens were
negative, which indicated that the patient had no preexist-
ing flavivirus antibodies. An immunoglobulin (Ig) M
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 9, September 2005 1449
*Universidad Autonomo de Nuevo Leon, San Nicolas de Los
Garza, Nuevo Leon, Mexico; †University of Texas Medical Branch,
Galveston, Texas, USA; ‡Servicios de Salud de Sonora,
Hermosillo, Sonora, Mexico; and §Colorado State University, Fort
Collins, Colorado, USAenzyme-linked immunosorbent assay (11), performed on
the acute-phase specimen and a 30-day convalescent-
phase serum specimen in Sonora, demonstrated serocon-
version and the presence of WNV-reactive IgM antibodies
in the convalescent-phase serum sample. 
Viral RNA was extracted from the 2 WNV strains after
a single Vero cell passage directly from 140 µL of the
infected cell culture supernatants, using the QIAamp viral
RNA extraction kit (12). RT-PCR was performed by using
3 primer pairs to amplify the entire prM-E genes of each
WNV isolate as previously described (12). PCR products
were gel purified with the QIAquick kit (Qiagen, Valencia,
CA, USA) according to the manufacturer’s protocol, and
the resulting template was directly sequenced with the
amplifying primers. Sequencing reactions were performed
as described previously (8). Analysis and assembly of
sequencing data were performed with the Vector NTI Suite
software package (Informax, Frederick, MD, USA).
Nucleotide and deduced amino acid sequences of the 2004-
nucleotide region representing the prM-E genes from each
isolate were aligned with the AlignX program in the Vector
NTI Suite and compared to sequences of selected North
American WNV isolates for which the prM-E genes were
available in GenBank. Phylogenetic trees were constructed
by Bayesian analysis with the program MRBAYES, ver-
sion 2.0 (13), with the Metropolis-coupled, Markov chain,
Monte Carlo algorithm run with 4 chains over 150,000
generations under a general time-reversible model with a
burn-in time of 50,000 generations. Rate heterogeneity was
estimated by using a γ distribution for the variable sites.
The Bayesian consensus tree was compared to trees gener-
ated by neighbor-joining, maximum parsimony, and maxi-
mum likelihood analyses using PAUP, version 4.0b10 (14),
and each method generated trees with the same overall
topology. The consensus phylogram of the 40 WNV iso-
lates generated by Bayesian analysis (13) is shown in the
Figure, with confidence values at relevant nodes to demon-
strate statistical support for each clade. 
Conclusions
Comparison of the 2 Mexican isolates, NL-54
(GenBank accession no. AY963775) and human Sonora
(GenBank accession no. AY963774), to the prototypical
North American WNV isolate, WN-NY99 (GenBank
accession no. AF196835), 2 previous Mexican isolates,
MexNL-03 (GenBank accession no. AY426741) (7) and
TM171-03 (GenBank accession no. AY371271) (2), and
an isolate collected in Harris County, Texas, in 2002
(GenBank accession no. AY185906) (15) indicated
nucleotide and deduced amino acid differences and simi-
larities among each of the isolates. Table 2 shows the posi-
tions at which nucleotide and amino acid substitutions
were found. Both the Mexican mosquito and human iso-
lates reported herein shared a nucleotide mutation at posi-
tion 660 (C to U) of the prM gene and 2 mutations at
positions 1442 (U to C) and 2466 (C to U) of the E gene.
Each of these 3 mutations was shared with a 2003 horse
strain from Nuevo Leon (MexNL-03) (7) and a 2002 bird
isolate from Harris County, Texas (TX-1) (15). The muta-
tion at nucleotide 1442 also represented a deduced amino
acid substitution in the envelope protein (V159A). The
Mexican mosquito and human isolates reported herein
shared a unique mutation at genomic position 1320 (A to
G) in the E gene. The human isolate also had 3 additional
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Figure. Phylogram of 2 West Nile viruses (WNV) isolated from a
mosquito pool and human serum in Mexico (shown in bold). The
phylogenetic tree was generated by Bayesian analysis of a 2004-
nucleotide region of the prM and E genes of 40 WNV isolates root-
ed by the most closely related Old World strain, Israel 1998.
Bayesian confidence values are shown to provide statistical sup-
port for each clade.mutations in the E gene at positions 1074 (G to A), 1656
(U to C), and 1974 (C to U). Each of the additional
nucleotide mutations was silent. The nucleotide mutations
at nucleotide positions 660, 1442, and 2466 have also been
described in most WNV isolates sequenced from Texas,
Illinois, and Colorado in 2002 (12). This finding suggests
that isolates obtained from northern states of Mexico (i.e.,
Nuevo Leon and Sonora) were derived from WNV strains
circulating in the western United States. Only a single
mutation at position nucleotide 2466 was shared by these
2 isolates and a 2003 bird isolate from Tabasco State
(TM171-03). This finding supports results from earlier
studies that suggest separate introductions of WNV into
Mexico (2,7). Phylogenetic trees generated by a number of
methods indicate that the recent Mexican mosquito and
human isolates belong to the clade comprised of WNV iso-
lates collected outside the northeastern United States after
2001, with the exception of isolates collected along the
southeast coast of Texas. (Those isolates constitute a sepa-
rate, sister clade relative to all other North American WNV
isolates sequenced to date [Figure].). Because of a shared
mutation between the recent Mexican mosquito and
human isolates, these 2 virus strains constitute a distinct
subclade within the larger US 2002 clade that is supported
by strong Bayesian confidence values (94%). The accumu-
lation of 3 additional nucleotide mutations in the 2004
Mexican human isolate is illustrated by longer branch
lengths in comparison to the 2003 mosquito pool isolate
NL-54, which suggests the continued microevolution of
WNV in Mexico from year to year. 
Our patient represents the first reported autochthonous
human case of confirmed WNV infection in Mexico. The
paucity of human cases reported to date from Mexico is
curious for several reasons: 1) a large number of cases are
reported from the United States, 2) available evidence
indicates that WNV is now widely distributed in Mexico
(1–7), 3) most of the WNV virus strains circulating in the
republic are genetically similar to those in the United
States (Figure). One explanation for this difference could
be the failure of local health personnel to recognize the
various clinical forms of WNV infection. As illustrated by
our patient, West Nile fever can easily be mistaken for
dengue fever. A second reason may be the difficulty of
making a serologic diagnosis of WNV infection among
persons living in geographic regions where several differ-
ent flaviviruses circulate, and people have multiple fla-
vivirus infections (11). A third and related possibility is
that WNV infection may be less severe in persons with
preexisting heterologous flavivirus antibodies (11). 
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